Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chih-Ping Lin

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Therapeutic Advances in Endocrinology and Metabolism|December 22, 2025
Glucagon-like peptide-1 receptor agonists linked to a reduced risk of developing asthma among patients with type 2 diabetesYung-Sheng Cheng, Chi-Hsiang Chung, Shih-Ming Kuo, et al.
Diabetology & Metabolic Syndrome|May 17, 2023
Gender-specific impacts of thigh skinfold thickness and grip strength for predicting osteoporosis in type 2 diabetesChieh-Hua Lu, Chien-Hsing Lee, Li-Wei Wu, et al.
Medicine|March 10, 2023
The efficacy and safety of combined GLP-1RA and basal insulin therapy among inadequately controlled T2D with premixed insulin therapyJhih-Syuan Liu, Sheng-Chiang Su, Feng-Chih Kuo, et al.
Plos One|May 2, 2024
The role of traditional Chinese medicine on fracture surgery, hospitalization, and total mortality risks in diabetic patients with osteoporosisYi-Chen Liu, Chi-Hsiang Chung, Chien-Jung Lin, et al.
Medicine|February 10, 2025
Glucagon-like peptide-1 receptor agonists therapy to attenuate the risk of knee osteoarthritis and total knee replacement in type 2 diabetes mellitus: A nation-wide population-based cohort studyChih-Ping Lin, Chi-Hsiang Chung, Chieh-Hua Lu, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Therapeutic Advances in Endocrinology and Metabolism|December 22, 2025
Glucagon-like peptide-1 receptor agonists linked to a reduced risk of developing asthma among patients with type 2 diabetesYung-Sheng Cheng, Chi-Hsiang Chung, Shih-Ming Kuo, et al.
Diabetology & Metabolic Syndrome|May 17, 2023
Gender-specific impacts of thigh skinfold thickness and grip strength for predicting osteoporosis in type 2 diabetesChieh-Hua Lu, Chien-Hsing Lee, Li-Wei Wu, et al.
Medicine|March 10, 2023
The efficacy and safety of combined GLP-1RA and basal insulin therapy among inadequately controlled T2D with premixed insulin therapyJhih-Syuan Liu, Sheng-Chiang Su, Feng-Chih Kuo, et al.
Plos One|May 2, 2024
The role of traditional Chinese medicine on fracture surgery, hospitalization, and total mortality risks in diabetic patients with osteoporosisYi-Chen Liu, Chi-Hsiang Chung, Chien-Jung Lin, et al.
Medicine|February 10, 2025
Glucagon-like peptide-1 receptor agonists therapy to attenuate the risk of knee osteoarthritis and total knee replacement in type 2 diabetes mellitus: A nation-wide population-based cohort studyChih-Ping Lin, Chi-Hsiang Chung, Chieh-Hua Lu, et al.
Pageof 2